Yixintang Pharmaceutical Group Co., Ltd.

Simbol: 002727.SZ

SHZ

18.75

CNY

Tržna cena danes

  • 23.9311

    Razmerje P/E

  • 0.6980

    Razmerje PEG

  • 11.17B

    Kapaciteta MRK

  • 0.02%

    Donos DIV

Yixintang Pharmaceutical Group Co., Ltd. (002727-SZ) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ). Prihodki podjetja prikazujejo povprečje NaN M, ki je NaN % gowth. Povprečni bruto dobiček za celotno obdobje je NaN M, ki je NaN %. Povprečno razmerje bruto dobička je NaN %. Rast čistega dobička za lanskoletno poslovanje podjetja je NaN %, kar je enako NaN % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja Yixintang Pharmaceutical Group Co., Ltd., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na . Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini NaN. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo NaN v valuti poročanja. Letna sprememba tega vidika je NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009

balance-sheet.row.cash-and-short-term-investments

03895.335202532.4
1624
1459.5
1351.9
2196
1594.7
1033.9
1056.3
520.4
386.1
386.5
378.6
216.6

balance-sheet.row.short-term-investments

0219.78.4297.3
-552.1
-493.9
81
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

01991.724111777.5
1422.5
1160.9
1192.1
1160.8
1100.1
907.4
660.4
562
404.9
303.9
256.5
195.4

balance-sheet.row.inventory

03852.63387.43317
2194.5
2028
1866
1626.3
1373.4
1024.3
766.4
608
448.7
401.1
316.9
212.6

balance-sheet.row.other-current-assets

0153.3139.265.5
1477.1
959.3
646.9
13.1
325.1
48
-84.2
-65.5
-47.5
-38.1
-35.5
-24.4

balance-sheet.row.total-current-assets

09892.99457.67692.4
6718
5607.8
5056.8
4996.2
4393.4
3013.6
2398.9
1625
1192.3
1053.4
916.6
600.2

balance-sheet.row.property-plant-equipment-net

03995.63993.54080
690.5
585.6
535.6
509.3
497.4
474.1
412.1
345.3
271.8
210
150.7
53.8

balance-sheet.row.goodwill

01649.61397.21380
1102.2
1061.1
1077.1
1057.7
796
497
1.5
0
0
0
0
0

balance-sheet.row.intangible-assets

0184.1165.7122.9
122.9
90.5
84.7
82.7
88.1
62
29.3
14.7
15.5
16.3
13.1
14.8

balance-sheet.row.goodwill-and-intangible-assets

01833.71562.91502.8
1225.1
1151.6
1161.8
1140.4
884.2
559
30.9
14.7
15.5
16.3
13.1
14.8

balance-sheet.row.long-term-investments

0165.3131.4-190.1
635.7
577.4
0
0
176.4
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

088.994.158.5
27.6
22.4
28.9
45
49.8
42.8
30.2
25.4
13.6
5.9
2.5
1.3

balance-sheet.row.other-non-current-assets

0670.8939.51193.8
31.4
18.1
572.6
455.7
12
96.8
69.4
62.5
31.3
22.7
21.9
15.3

balance-sheet.row.total-non-current-assets

06754.56721.56645
2610.3
2355
2299
2150.4
1619.8
1172.6
542.6
447.8
332.1
254.9
188.1
85.2

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

016647.416179.114337.3
9328.3
7962.8
7355.9
7146.6
6013.2
4186.3
2941.4
2072.8
1524.4
1308.3
1104.7
685.4

balance-sheet.row.account-payables

02560.24328.83805.9
2875.8
2316.1
2031.9
1699.7
1513.7
1065.7
722.7
680.1
493.4
449.4
373.9
237.7

balance-sheet.row.short-term-debt

03333.91335.51143.9
60.1
0
798.9
100
0.7
625
0
220
156
195.3
180.2
110.8

balance-sheet.row.tax-payables

081.4250.4164.1
105.8
129.3
158.1
146.1
22
52
27.4
28.7
14.5
8.9
27.9
24

balance-sheet.row.long-term-debt-total

01552.21758.51764.1
1795.5
482.8
0
796.5
794.2
0
0
0
0
3.3
3.3
6.8

Deferred Revenue Non Current

01.212.213.3
15.8
39.2
17.2
13.6
10
6.4
3
3.2
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

01191.91055.812.7
8.6
74.1
458.3
842.8
804.9
4.4
133.1
8.2
4.5
1.6
0.6
0.5

balance-sheet.row.total-non-current-liabilities

01557.31774.71781
15.8
540.2
17.2
810.2
804.3
6.4
3
3.2
2.2
5.3
5.3
6.8

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

01552.21756.71729
1795.5
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

08757.18651.57664.8
3547.8
3366.6
3306.4
3452.7
3515.1
1913.3
858.7
1022.7
713.6
679.5
607.3
422.6

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0596596596.2
595.3
567.8
567.8
567.8
520.6
260.3
260.3
195.2
195.2
195.2
195.2
175.7

balance-sheet.row.retained-earnings

04646.44335.43504.2
2834.4
2268.4
1876.3
1561.7
1272.7
1074.5
906.4
627.7
405.1
237.1
113.3
49.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

0377.8424.9405.6
279.8
356.6
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

02125.82069.82071.7
2056
1402.2
1601.5
1564.5
703.1
938.2
916
224.3
206.1
191.5
181
33.2

balance-sheet.row.total-stockholders-equity

077467426.16577.7
5765.4
4594.9
4045.6
3693.9
2496.4
2273
2082.7
1047.2
806.4
623.8
489.5
258.2

balance-sheet.row.total-liabilities-and-stockholders-equity

016647.416179.114337.3
9328.3
7962.8
7355.9
7146.6
6013.2
4186.3
2941.4
2072.8
1524.4
1308.3
1104.7
685.4

balance-sheet.row.minority-interest

0131101.494.8
15.1
1.2
4
0
1.8
0
0
2.9
4.4
5
8
4.6

balance-sheet.row.total-equity

078777527.66672.5
5780.5
4596.2
4049.5
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0385139.8107.2
83.6
83.5
81
12
176.4
0
3.9
3.4
2.9
2.7
2.7
2.5

balance-sheet.row.total-debt

04886.130942908
60.1
482.8
798.9
896.5
794.9
625
0
220
156
198.5
180.2
110.8

balance-sheet.row.net-debt

01210.5-417.6672.9
-1564
-976.7
-553
-1299.5
-799.8
-408.9
-1056.3
-300.4
-230.1
-188
-198.3
-105.8

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Yixintang Pharmaceutical Group Co., Ltd. opazno spremenil prosti denarni tok, ki se je spremenil v NaN. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo NaN, kar kaže na razliko NaN v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini NaN v valuti poročanja. To je premik za NaN v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila NaN, NaN in NaN, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila NaN, pri čemer je razlika v primerjavi z letom prej znašala NaN. Poleg tega je podjetje namenilo NaN za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane NaN, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009

cash-flows.row.net-income

0549.41013917.2
789.2
603.3
519.8
422.7
353.6
346.4
295
239.4
182
132.8
102.9
84.8

cash-flows.row.depreciation-and-amortization

001000.61087.8
79.8
73.4
74.4
72.9
66.6
51.5
37.4
24.7
22.3
19.3
0
0

cash-flows.row.deferred-income-tax

00-35.1-27.3
-23.4
3.4
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0014.240.4
32.4
-3.4
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

00-9.7-603.9
30.6
114.1
-49.1
-256.2
-234
-340.5
-214
-87.9
-83.6
-81.8
0
0

cash-flows.row.account-receivables

00-765.8-739.7
-279.4
40.8
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

00-234.9-1236.8
-237.1
-206.1
-229.8
-333.8
-386
-304.3
-167.7
-165.9
-48.6
-83.9
0
0

cash-flows.row.account-payables

001026.11399.9
570.5
276
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

00-35.1-27.3
-23.4
3.4
180.7
77.6
151.9
-36.2
-46.3
78
-35
2.2
0
0

cash-flows.row.other-non-cash-items

0-549.4514.1377.5
124.9
192.1
90.7
151.7
6.5
128.3
57.8
52
37
31.2
-102.9
-84.8

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

00-349-391.6
-280.2
-206.9
-156
-142
-146.1
-194
-158.6
-145.4
-103.8
-97.6
-139.6
-26.9

cash-flows.row.acquisitions-net

00-4.7-65.1
3.4
1.4
-11.6
-3.5
-47.3
0
0.4
0
0
0
1.2
0

cash-flows.row.purchases-of-investments

00-980.5-1976.5
-5195
-3320.9
-3015.5
-250.7
-390
-506.7
-6.9
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

001207.22901.8
4728.6
3022.1
2358.2
518
125
12
159
0
0
0
0
0

cash-flows.row.other-investing-activites

00-94.7-336.9
-181.5
-52.7
-69.3
-407.3
-210.5
-66.5
-158.6
0.1
0.6
0.3
8.3
4.8

cash-flows.row.net-cash-used-for-investing-activites

00-221.7131.7
-924.7
-556.8
-894.3
-285.6
-668.9
-755.2
-164.7
-145.3
-103.2
-97.3
-130.1
-22.1

cash-flows.row.debt-repayment

00-207.9-137.1
-51.1
-800
-514
-850.7
-532.1
-83
-320
-186
-349.5
-282.9
-249
-111.8

cash-flows.row.common-stock-issued

0020.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

00-2-0.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

00-191.6-180.9
-175
-200.3
-211.6
-168.5
-133.9
-166.4
-8.6
-12.5
-12.4
-10.6
-35.4
-4.9

cash-flows.row.other-financing-activites

00-678.6-986.8
177.6
596.9
5.3
1462
1591.3
708
849
250
307
297.2
469.5
173.8

cash-flows.row.net-cash-used-provided-by-financing-activities

00-1078.2-1304.8
-48.4
-403.3
-720.4
442.8
925.4
458.6
520.5
51.5
-55
3.7
185.1
57.1

cash-flows.row.effect-of-forex-changes-on-cash

000.3-0.1
-0.2
0.1
0.5
-0.1
0.1
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

001197.5618.5
60
22.8
-978.4
548.3
449.1
-110.9
531.9
134.4
-0.5
8
161.9
90.3

cash-flows.row.cash-at-end-of-period

02859.52859.51661.9
1043.5
983.4
960.6
1939
1390.7
941.5
1052.4
520.4
386.1
386.5
378.6
216.6

cash-flows.row.cash-at-beginning-of-period

02859.51661.91043.5
983.4
960.6
1939
1390.7
941.6
1052.4
520.4
386.1
386.5
378.6
216.6
126.3

cash-flows.row.operating-cash-flow

002497.11791.7
1033.4
982.9
635.8
391.2
192.6
185.8
176.2
228.2
157.7
101.6
0
0

cash-flows.row.capital-expenditure

00-349-391.6
-280.2
-206.9
-156
-142
-146.1
-194
-158.6
-145.4
-103.8
-97.6
-139.6
-26.9

cash-flows.row.free-cash-flow

002148.11400
753.2
776.1
479.7
249.1
46.5
-8.3
17.6
82.8
53.9
4
-139.6
-26.9

Vrstica izkaza poslovnega izida

Prihodki Yixintang Pharmaceutical Group Co., Ltd. so se v primerjavi s prejšnjim obdobjem spremenili za NaN%. Bruto dobiček podjetja 002727.SZ znaša NaN. Odhodki iz poslovanja podjetja so NaN in so se v primerjavi s prejšnjim letom spremenili za NaN%. Odhodki za amortizacijo znašajo NaN, kar je NaN% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini NaN, ki kaže NaN% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo NaN, kar pomeni NaN% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša NaN in predstavlja NaN% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so NaN, ki kažejo NaN% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je NaN%. Čisti prihodki v zadnjem letu so znašali NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009

income-statement-row.row.total-revenue

017301.417431.614587.4
12656.3
10479.1
9176.3
7751.1
6249.3
5321.2
4428.4
3546.7
2842.1
2218.5
1850.2
1456

income-statement-row.row.cost-of-revenue

011750.311322.39196.5
8123
6424.1
5457
4532.5
3669.4
3090.3
2637.8
2142.5
1758
1355.9
1159.9
925

income-statement-row.row.gross-profit

055516109.35390.9
4533.3
4055
3719.2
3218.6
2579.9
2230.9
1790.6
1404.2
1084.2
862.6
690.2
531

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-106.6349.1320.6
437.6
343.3
414.3
367.8
18.5
12.8
2.4
6.4
6.3
2
2.4
-4.5

income-statement-row.row.operating-expenses

04717.54496.84091.3
3558.9
3250.3
2924.5
2574.6
2110.1
1791.6
1386.7
1117.6
867.4
694.5
559.8
414.5

income-statement-row.row.cost-and-expenses

016467.815819.113287.8
11681.9
9674.4
8381.5
7107.2
5779.5
4881.9
4024.5
3260.1
2625.4
2050.4
1719.7
1339.4

income-statement-row.row.interest-income

0-77.653.439.2
24.2
19
12.4
10.7
12.2
13.6
8.6
6.3
4.9
4
0
0

income-statement-row.row.interest-expense

0135.3147.1136.2
24.5
33.7
47.6
57.6
37.5
20.4
8.1
12.9
12.4
10
4.8
6

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-123.6-426.928.6
39
9.8
7.3
-140.5
-60.4
-49.1
-58.6
-16.6
-11.9
-10.2
-4.6
-11.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-106.6349.1320.6
437.6
343.3
414.3
367.8
18.5
12.8
2.4
6.4
6.3
2
2.4
-4.5

income-statement-row.row.total-operating-expenses

0-123.6-426.928.6
39
9.8
7.3
-140.5
-60.4
-49.1
-58.6
-16.6
-11.9
-10.2
-4.6
-11.8

income-statement-row.row.interest-expense

0135.3147.1136.2
24.5
33.7
47.6
57.6
37.5
20.4
8.1
12.9
12.4
10
4.8
6

income-statement-row.row.depreciation-and-amortization

01332.41000.61397.7
229.8
184.9
222.4
72.9
66.6
51.5
37.4
24.7
22.3
19.3
8.7
8.5

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0833.51661.91067.9
917.9
739.2
684.3
687.4
392.6
379
344.4
264.3
198.9
156.3
123.9
109.8

income-statement-row.row.income-before-tax

0709.912351096.5
956.9
749.1
691.7
546.9
409.4
390.1
345.3
269.9
204.8
157.9
125.9
104.8

income-statement-row.row.income-tax-expense

0142.2222179.3
167.7
145.7
171.9
124.1
55.8
43.7
50.3
30.6
22.9
25.1
24.4
20

income-statement-row.row.net-income

0549.41010921.6
790
603.9
521.1
422.7
353.4
346.4
297.3
240.9
182.6
134.7
102.9
84.8

Pogosto zastavljeno vprašanje

Kaj je Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ) skupna sredstva?

Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ) skupna sredstva so 16647375283.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.318.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je 3.367.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je 0.031.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so 0.045.

Kaj je Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je 549441525.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 4886107552.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 4717493463.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 0.000.